The Global Congress on Obesity, Diabetes and Metabolic Health addresses obesity, diabetes, and metabolic health through innovations in pharmacology, digital health, personalized care, and global management strategies.
Highlights
Oral GLP-1 Receptor Agonists
CRISPR-Edited Islet Cells for Type 1 Diabetes
Once-Weekly Insulin Therapies
Dual Incretin Agonists (GLP-1 + GIP)
Implantable Continuous Glucose Monitors (CGMs)
GLP-1 Receptor Agonists for Cardiovascular & Renal Protection
Digital Twin Models for Personalized Diabetes Care
Automated Insulin Delivery Systems / Closed-Loop Pumps
AI & Machine Learning for Glucose Prediction and Diabetes Management
Continuous Ketone Monitoring for High-Risk Patients
Personalized Pharmacological Strategies
ADA Standards of Care in Diabetes
Real-World Evidence & Outcomes in Diabetes Treatment
Evidence-Based Dietary Interventions
Global Targets & Strategies to Halt Diabetes Rise
Management of Comorbidities in Diabetes (Obesity, Hypertension, Dyslipidemia)
Diabetes Education & Awareness Programs
Access to Affordable Insulin Worldwide
Collaborative International Research in Diabetes
Innovations in Diabetes Care in Low-Resource Settings
Who should Attend
Obesity Specialists and Nutritionists
Endocrinologists and Diabetologists
Primary Care Physicians and Healthcare Providers
Researchers and Academicians
Pharmaceutical and Medical Device Industry Professionals
Global Congress on Obesity, Diabetes and Metabolic Health - 20-21 Aug 2026, Paris, France (107525)
Global Congress on Obesity, Diabetes and Metabolic Health 2027
Important
Please, check "Global Congress on Obesity, Diabetes and Metabolic Health" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Diabetes, Metabolism, Nutrition
